Amitava BanerjeeAdnan SharifAbeer M. ShaabanDesley NeilSamantha WarrenJonathan N TownendCharles J. FerroRichard D ThompsonRachel K CrowleyMiruna D DavidGlenn Kunnath BonneyJames T GristDipak KotechaTim JonesDavid McWilliamsJane FletcherHelle Krogh PedersenN BhalaMark CookP Sherwood BurgeSusan P MollanManoj RaghavanF EvisonN AroraTonny V VeenithJames GlasbeyNeil J HowellHeena KhiroyaShaun BoltonPaolo MuiesanDavid T RollingsAdam BoultonCarly WelchRoss G EdgarPankaj PuniaS GhoshGill CombesStephanie B WitheyRobin P DaviesTerence A Jones
P108
Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCTA Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)Use of Low-dose Zolpidem in Parkinson's DiseaseCytomegalovirus Control in Critical CareSteroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit SitesLong Term Extension Trial of SetmelanotideTargeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's DiseaseKRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK InhibitorTAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)Effectiveness and Cost-effectiveness of a Tailored Text Message Programme (MiQuit) for Smoking Cessation in PregnancyStudy to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid.Frailty Intervention Trial in End-Stage Patients on DialysisPostoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceA Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary CholangitisEPA for Metastasis Trial 2Efficacy of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell LymphomaA Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical ResectionA 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate CancerA Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic FibrosisLong-term Safety and Efficacy Extension Trial of Bimatoprost SRIbrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell LymphomaSeladelpar in Subjects With Primary Biliary Cholangitis (PBC)
P6153
Q37607251-FECA00F1-7B8B-4FDE-82F6-9101D290CAA7Q38329268-CD0201FB-45CE-4E3B-A30C-7AEE3FF776E8Q40610287-91D594BD-67B5-4223-9A76-3071C6988704Q42596349-B7C32A05-9825-4331-99FD-FA1A12CEE106Q43111018-D38541D0-55C3-4E85-AC20-4C36A749321EQ43194026-4053D1F0-E4F1-49FE-BBE7-6C790ADFF36DQ43252027-FB44002F-4F35-4F8A-99A9-CD760653C260Q43288566-83393C40-CE74-45D8-8BA8-14656CFAC478Q43662692-139D6B52-321C-4BAC-B140-73BB4681E967Q47405150-A84AE026-DA6C-428A-9012-43F8FF714F3FQ47503128-00C4A19D-8056-47B5-B5BB-81266D7C5FE9Q47503128-0E657548-2FD4-44CD-896C-F3463C19779EQ47503128-65552A5B-C5BD-4150-BCAE-A118AFB7FE17Q47756372-AFAC76BF-7550-4113-820A-FF03928A79E6Q47805074-CA39B1A1-F968-460E-863F-77A273D044ECQ48924303-28ea16d1-48a8-e4da-e059-21165b70bb1bQ50054804-EA72E5C8-C49C-41D4-A5AD-F8AF05F80E5CQ50054804-FFCF8B4B-59FF-4394-91C7-E5B25521A6D9Q51774049-E9A2E2E0-AA0D-42B3-B290-AA928DA24624Q54152846-6907FA52-094F-4EB8-977C-C748C5FA9554Q54172340-66D49E93-9552-476F-A75D-3FC63AE28051Q54437674-63E5B09A-33B8-43C4-9615-69C531D4D15CQ55727166-0DA15AE0-900E-4354-A46F-475285A28A57Q56333911-B374CC52-D2D7-470B-BDBB-59B2948AD582Q56432956-BF35C910-205E-4795-9EC4-D1C31AFA43A2Q56913466-BA4C7D75-7FAA-4C34-94B0-26D39941E03AQ56983562-84A2C710-579C-4547-A3BD-F4320558FAF5Q57320537-6FD0E40E-A705-4D6E-82A6-B38FC36D9034Q57345647-B077A24B-02AE-462E-88E0-CFE87E6644CCQ58131855-98FA2138-1B7F-4263-BBCB-A57E80D6392EQ59680197-C4C72E9F-5CCB-4485-9A8D-18DAD8E2BAC9Q59828644-C6583709-C7FF-4811-A5CB-BDEB330E461BQ59829883-A307EF28-5672-4F97-A45B-77A0C960D26EQ60030878-D87FBE8A-8817-4BDC-AB03-D6D0DD30C019Q60546715-5BA81648-6D2B-475A-8377-8C2C0B1D1AB1Q60965190-7C08033E-3F82-4C0F-80FE-1C36FB5AB4DDQ60968007-4B489C1E-9EF9-4776-BFE1-BA53EB1F8492Q60968007-A816ABCA-4702-47D1-81B8-A778F54AD51AQ60968007-BC56A0D0-2FAF-40EF-B658-867D474EE3F0Q60968007-F8BBFD8D-D199-4A8D-89F8-F55B9691D3BE
P108
name
University Hospitals Birmingham NHS Foundation Trust
@en
type
label
University Hospitals Birmingham NHS Foundation Trust
@en
prefLabel
University Hospitals Birmingham NHS Foundation Trust
@en
P214
P244
P6366
P131
P1602
university-hospitals-nhs-foundation-trust-7564
P2002
P2013
P213
0000 0004 0376 6589
P214
P2427
grid.412563.7
P244
n2009184141
P3608
GB654965101
P4527
P5785
P6366
1308923049
P6782
P7859
lccn-n2009184141
P8167
university_hospitals_birmingham_nhs_foundation_trust